Lubiprostone (Standard)

Overview

Lubiprostone (Standard) is the analytical standard of Lubiprostone. This product is intended for research and analytical applications. Lubiprostone (SPI-0211) increases intestinal fluid secretion through generation of CIC-2 / CFTR and activation of cAMP signaling pathway. Lubiprostone inhibits myeloperoxidase (MPO) activity, downregulates Indomethacin ( HY-14397 )-induced iNOS and TNFα expression. Lubiprostone can be used for chronic constipation research.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Immunology/Inflammation | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Glutathione Peroxidase | Products > Signaling Pathways > NO Synthase | Products > Signaling Pathways > TNF Receptor | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Chloride Channel | Products > Signaling Pathways > CFTR

Product Information

• Catalog No.: HY-B0679R
• CAS No.: 136790-76-6
• Molecular Formula: C20H32F2O5
• Molecular Weight: 390.46
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source